People with multiple sclerosis (MS) visited doctors, were admitted to the hospital, and used emergency care more often than…
Articles by Margarida Maia, PhD
The rates of people with multiple sclerosis (MS) who advance from a relapsing disease course to a secondary progressive…
Following the MIND diet plan, rich in leafy greens, whole grains, legumes, nuts, berries, and lean meats, may help strengthen…
In healthy adults, a single low dose of Immutep’s immunosuppressive candidate IMP761 continues to be safe and appears to…
People who develop multiple sclerosis (MS) at a younger age tend to consistently have better physical health but worse…
Ambio Life Sciences has launched a clinical program to test ibogaine — an experimental, naturally occurring psychedelic — for…
Enrollment is now complete in the twin Phase 3 clinical trials testing Immunic Therapeutics‘ oral small molecule vidofludimus…
Body mass index (BMI), a measure commonly used measure of body fat based on a person’s height and weight, does…
Almost two years of treatment with fenebrutinib — an investigational oral tablet for multiple sclerosis (MS) — helped…
While subtle symptoms of multiple sclerosis (MS) — like muscle weakness, fatigue, and numbness or unusual sensations — are…
Half of multiple sclerosis (MS) patients in the U.K. who work have compromised their health by staying in jobs…
A 10-week program that combines cognitive behavioral therapy — a technique focused on understanding the connection between thoughts, feelings, and…
Stem cells from donated placentas appear safe and may help reduce symptoms of secondary progressive multiple sclerosis (MS), according…
Three months of daily supplements containing ellagic acid — an antioxidant found naturally in many fruits and plants — significantly…
Non-pharmacological interventions such as mindfulness and exercise may improve sleep for people with multiple sclerosis (MS) while boosting overall…
As multiple sclerosis (MS) progresses, the disease may reduce the number of mitochondrial DNA copies, suggesting the number of…
Injections of methotrexate into the spinal canal given every three months were safe and well tolerated, and helped adults with…
Vidofludimus calcium, an experimental oral therapy from Immunic Therapeutics, reduced the risk of confirmed disability worsening and slowed brain…
The healthcare costs of secondary progressive multiple sclerosis (SPMS) are high, according to a real-world study in Spain, and…
Biostate AI is partnering with the nonprofit Accelerated Cure Project (ACP) to develop a series of artificial intelligence (AI)…
Frexalimab, an experimental antibody-based medication, was well tolerated and maintained disease control over two years in adults with relapsing forms…
A Phase 4 observational study called ENABLE is enrolling adults with relapsing forms of multiple sclerosis (MS) across the…
MS Canada is calling on everyone across Canada to tune up their bikes and join one of the many…
Treatment during pregnancy with the approved multiple sclerosis (MS) medication Copaxone (glatiramer acetate injection) does not appear to increase…
Quantum Biopharma is partnering with researchers at Massachusetts General Hospital in Boston on a clinical study to test a positron…
No added benefit was found in increasing the dose of Genentech’s Ocrevus (ocrelizumab) — to two to three times…
The AdventHealth Neuroscience Institute is recruiting patients for a Phase 1b clinical trial testing IDP-023, an off-the-shelf cell-based treatment that…
A researcher and neurologist at Penn Medicine in Philadelphia has won the 2025 John Dystel Prize for Multiple Sclerosis…
“Caregiving,” a two-hour documentary film centered on the daily experiences of six family and professional caregivers in the U.S.
For every 1,000 employees in the U.S., about $580,000 is spent each year in excess healthcare costs and lost work…